ARCHIVES

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

Harvard’s Harvey Fineberg Is Elected IOM President.

November 16, 2001

NCI Formaldehyde Finding Criticized

March 7, 1986